Cytokinetics
CYTK
CYTK
261 hedge funds and large institutions have $3.83B invested in Cytokinetics in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 83 increasing their positions, 96 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
14% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 96
21% less capital invested
Capital invested by funds: $4.88B → $3.83B (-$1.05B)
26% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 47
Holders
261
Holding in Top 10
9
Calls
$13.4M
Puts
$8M
Top Buyers
| 1 | +$52.7M | |
| 2 | +$49.3M | |
| 3 | +$37.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$34.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30.1M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$21.7M | |
| 3 | -$17.4M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$16.9M |
| 5 |
Morgan Stanley
New York
|
-$16M |